Symbols / IKNA
IKNA Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-08-07 08:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Analyst Upgrade: Can IKNA stock sustain free cash flow growth - July 2025 Outlook & Daily Chart Pattern Signal Reports - Naître et grandir Sat, 07 Mar 2026 10
- Ikena Oncology Shareholders Green Light Inmagene Merger: What the 1-for-12 Split Means for Investors - Stock Titan ue, 15 Jul 2025 07
- Ikena Oncology and Inmagene Announce Merger and Fundraising - Yahoo Finance ue, 24 Dec 2024 08
- ImageneBio, Inc. Announces Merger Completion with Ikena Oncology, Begins Trading on Nasdaq Under 'IMA' - Quiver Quantitative Fri, 25 Jul 2025 07
- Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement - GlobeNewswire Mon, 23 Dec 2024 08
- Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer - Stock Titan Wed, 21 Feb 2024 08
- Guidance Update: Is CXAI stock forming a triangle pattern - July 2025 Intraday Action & Stock Portfolio Risk Control - baoquankhu1.vn Sat, 07 Mar 2026 01
- Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction - GlobeNewswire Mon, 07 Aug 2023 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for IKNA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|